KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alnylam Pharmaceuticals (ALNY) Other Working Capital Changes (2016 - 2025)

Historic Other Working Capital Changes for Alnylam Pharmaceuticals (ALNY) over the last 17 years, with Q4 2025 value amounting to $170.7 million.

  • Alnylam Pharmaceuticals' Other Working Capital Changes rose 143227.17% to $170.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was $117.7 million, marking a year-over-year increase of 15000.04%. This contributed to the annual value of $117.7 million for FY2025, which is 15000.04% up from last year.
  • Alnylam Pharmaceuticals' Other Working Capital Changes amounted to $170.7 million in Q4 2025, which was up 143227.17% from -$12.5 million recorded in Q3 2025.
  • Alnylam Pharmaceuticals' 5-year Other Working Capital Changes high stood at $170.7 million for Q4 2025, and its period low was -$295.0 million during Q2 2024.
  • Over the past 5 years, Alnylam Pharmaceuticals' median Other Working Capital Changes value was $2.5 million (recorded in 2023), while the average stood at -$9.0 million.
  • Its Other Working Capital Changes has fluctuated over the past 5 years, first crashed by 126723.43% in 2022, then skyrocketed by 143227.17% in 2025.
  • Over the past 5 years, Alnylam Pharmaceuticals' Other Working Capital Changes (Quarter) stood at $9.7 million in 2021, then crashed by 1267.23% to -$113.1 million in 2022, then surged by 115.64% to $17.7 million in 2023, then crashed by 172.42% to -$12.8 million in 2024, then soared by 1432.27% to $170.7 million in 2025.
  • Its Other Working Capital Changes was $170.7 million in Q4 2025, compared to -$12.5 million in Q3 2025 and -$73.2 million in Q2 2025.